The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse Efficacy of Esomeprazole 40mg Once Daily Versus Placebo and Esomeprazole 20mg Once Daily Versus Placebo in Treatment for Relief of Upper Gastrointestinal Symptoms Associated with Continuous Use of NSAIDS Including COX-2 Selective NSAIDS
- collapse A Four-way Cross-over Multiple-dose Open-label Pharmacokinetic Drug Interaction Study with Esomeprazole 20 mg b.i.d., Metronidazole 500 mg b.i.d., Clarithromycin 250 mg b.i.d., and their combination b.i.d. in Healthy Non-smoking Male and Female Subjects.
- collapse A randomised, comparative, double-blind, parallel group, multi-centre Phase IIIa study to eradicate Helicobacter Pylori, heal gastric ulcer and prevent relapse in gastric ulcer subjects with esomeprazole in combination with amoxicillin and clarithromycin.
- collapse PPI Comparator Study to Compare the Efficacy of Healing and Maintenance treatment with Esomeprazole and Pantoprazole in Subjects with Reflux Oesophagitis - A Multi-Centre, Randomized, Double-Blind Study - EXPO
- collapse Evaluating the benefit of continuous versus on demand H199/18 therapy: A randomised study on the efficacy of maintenance therapy in gastroesophageal reflux disease patients (BRILLIANT)
- collapse On demand vs continous treatment of endoscopy negative subjects with gastroesophageal reflux disease (GERD) with esomeprazole 20 mg o.d. over a 6 months long term treatment phase. An open, randomised, multicenter study - NEED
- collapse A randomized, double-blind, parallel-group multicenter efficacy and safety phase IIB pilot study of Esomeprazole 40mg b.i.d. versus Placebo b.i.d. in adult asthmatics treated for 4 months..
- collapse Suppotive Test for Acid Related Symptoms (STARS II) with esomeprazole and a following 7-week, double-blind, randomized, placebo controlled treatment period in uninvestigated subjects with upper gastrointestinal symptoms.
- collapse Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
- collapse Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments
